TURKISH NEUROSURGERY, cilt.26, sa.4, ss.622-631, 2016 (SCI-Expanded)
AIM: To evaluate the neuroprotective effects of adalimumab in an experimental spinal cord injury model and compare them with those of the widely-used methylprednisolone.